168 related articles for article (PubMed ID: 21368608)
21. 18F-FDG PET/CT for Molecular Imaging of Hepatoblastoma in Beckwith-Wiedemann Syndrome.
Derlin T; Hartung D; Hueper K
Clin Nucl Med; 2018 May; 43(5):e164-e165. PubMed ID: 29485435
[TBL] [Abstract][Full Text] [Related]
22. [Modern CT and PET/CT imaging of the liver].
Klasen J; Heusner TA; Riegger C; Reichelt D; Kuhlemann J; Antoch G; Blondin D
Radiologe; 2011 Aug; 51(8):671-9. PubMed ID: 21769701
[TBL] [Abstract][Full Text] [Related]
23. Focal nodular hyperplasia in identical twins.
Mindikoglu AL; Regev A; Levi JU; Casillas J; Schiff ER
Am J Gastroenterol; 2005 Jul; 100(7):1616-9. PubMed ID: 15984990
[TBL] [Abstract][Full Text] [Related]
24. Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.
Gutweiler JR; Yu DC; Kim HB; Kozakewich HP; Marcus KJ; Shamberger RC; Weldon CB
J Pediatr Surg; 2008 Dec; 43(12):2297-300. PubMed ID: 19040959
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
26. [Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
Grimm J; Müller-Hülsbeck S; Blume J; Biederer J; Heller M
Rofo; 2001 Mar; 173(3):266-72. PubMed ID: 11293872
[TBL] [Abstract][Full Text] [Related]
27. Imaging of focal liver lesions: the 90 %-rule.
Mostbeck G
Ultraschall Med; 2010 Dec; 31(6):545-7. PubMed ID: 21117006
[No Abstract] [Full Text] [Related]
28. Imaging of benign liver lesions.
Mathieu D; Caseiro-Alves F
JBR-BTR; 2004; 87(2):76-83. PubMed ID: 15174807
[No Abstract] [Full Text] [Related]
29. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
30. Castleman disease of the porta hepatis mimicking exophytic hepatocellular carcinoma on CT, MRI, and FDG PET/CT.
Dong A; Dong H; Zuo C
Clin Nucl Med; 2014 Jan; 39(1):e69-72. PubMed ID: 23486333
[TBL] [Abstract][Full Text] [Related]
31. FDG-PET-CT and whole-body MRI for triage in patients planned for radioembolisation therapy.
Schmidt GP; Paprottka P; Jakobs TF; Hoffmann RT; Baur-Melnyk A; Haug A; Notohamiprodjo M; Baur-Melnyk A; Nikolaou K; Reiser MF; Rist C
Eur J Radiol; 2012 Mar; 81(3):e269-76. PubMed ID: 21398060
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH
J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
34. Detection of liver metastases in patients with adenocarcinomas of the gastrointestinal tract: comparison of (18)F-FDG PET/CT and MR imaging.
Maegerlein C; Fingerle AA; Souvatzoglou M; Rummeny EJ; Holzapfel K
Abdom Imaging; 2015 Jun; 40(5):1213-22. PubMed ID: 25348732
[TBL] [Abstract][Full Text] [Related]
35. Focal nodular hyperplasia vs. hemangioma: computed tomography and magnetic resonance imaging findings.
Karahasanoglu R; Otcu H; Selcuk T; Ucar A; Kiris A
Ann Hepatol; 2011; 10(2):218-20. PubMed ID: 21502685
[TBL] [Abstract][Full Text] [Related]
36. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
37. Telangiectatic focal nodular hyperplasia of the liver: a case detected at birth.
Kim HS; Kim YA; Kim CJ; Suh YL; Jang JJ; Chi JG
J Korean Med Sci; 2003 Oct; 18(5):746-50. PubMed ID: 14555832
[TBL] [Abstract][Full Text] [Related]
38. CT findings and mistopathology of intratumoral steatosis in focal nodular hyperplasia: case report and review of the literature.
Stanley G; Jeffrey RB; Feliz B
J Comput Assist Tomogr; 2002; 26(5):815-7. PubMed ID: 12439320
[TBL] [Abstract][Full Text] [Related]
39. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
40. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
